Century Therapeutics, Inc.

Nasdaq:IPSC

Biological Products, (No Diagnostic Substances)·PHILADELPHIA, PA

A century is a period of 100 years or 10 decades. Centuries are numbered ordinally in English and many other languages.

CEO

Pfeiffenberger Brent

Financials

18 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/19/25	→
10-Q	Q3 2024	9/30/24	11/5/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
11/13/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
5/15/25	Q2 FY2025	→
3/19/25	Q1 FY2025	→
1/13/25	Q4 FY2025	→
11/5/24	Q4 FY2024	→
↓

News (8-K)

48 shown

Filed	Type	Description
1/23/26	Vote	Submission of Matters to a Vote of Security Holders	→
1/12/26	Reg FD	Regulation FD Disclosure	→
1/8/26	Agreement	Entry into a Material Definitive Agreement	→
12/29/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/12/25	Reg FD	Regulation FD Disclosure	→
12/9/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

20 shown

Filed	Form	Description
2/5/26	S-3	S-3	→
1/5/26	S-3/A	S-3/A	→
7/10/25	S-3	S-3	→
4/22/25	ARS	ARS	→
3/20/25	S-8	S-8	→
6/26/24	424B3	424B3	→
↓

Filing History(376 filings)

TypeDateAccessionPeriodSize

Feb 18, 2026

0001104659-26-017132OWNERSHIP DOCUMENT

Feb 13, 2026

4.8 KB

EFFECT

Feb 17, 2026

9999999995-26-000612

—

1.7 KB

SCHEDULE 13G/A

Feb 17, 2026

0000902664-26-001156

—

12.6 KB

Feb 5, 2026

0001867173-26-000004

Feb 3, 2026

4.8 KB

S-3

Feb 5, 2026

0001104659-26-010885S-3

—

530.4 KB

Feb 4, 2026

0002001162-26-000002

Feb 2, 2026

7.4 KB

Feb 4, 2026

0001867305-26-000002

Feb 2, 2026

8.1 KB

Feb 4, 2026

0002039294-26-000004

Feb 2, 2026

8.4 KB

Feb 4, 2026

0001867173-26-000002

Feb 2, 2026

7.3 KB

8-K

Jan 23, 2026

0001104659-26-006236FORM 8-K

Jan 22, 2026

189.9 KB

SCHEDULE 13G

Jan 16, 2026

0001346824-26-000006

—

19.4 KB

SCHEDULE 13G

Jan 16, 2026

0001738048-26-000002

—

34.5 KB

SCHEDULE 13G

Jan 16, 2026

0001831942-26-000002

—

14.8 KB

SCHEDULE 13G

Jan 15, 2026

0001193125-26-014129

—

141.3 KB

SCHEDULE 13G

Jan 15, 2026

0001172661-26-000198

—

13.9 KB

8-K

Jan 12, 2026

0001104659-26-002748FORM 8-K

Jan 12, 2026

6.7 MB

EFFECT

Jan 9, 2026

9999999995-26-000127

—

1.7 KB

8-K

Jan 8, 2026

0001104659-26-001952FORM 8-K

Jan 7, 2026

7.2 MB

Jan 6, 2026

0002039294-26-000002

Jan 2, 2026

5.8 KB

S-3/A

Jan 5, 2026

0001104659-26-000710S-3/A

—

108.9 KB

SCHEDULE 13G

Jan 5, 2026

0000902664-26-000035

—

16.9 KB

Dec 29, 2025

0002039294-25-000008

Dec 22, 2025

5.7 KB

8-K

Dec 29, 2025

0001104659-25-124836FORM 8-K

Dec 18, 2025

186.1 KB

Dec 16, 2025

0002001162-25-000009

Dec 12, 2025

5.1 KB

Dec 12, 2025

0002001162-25-000007

Dec 10, 2025

4.7 KB

25 filings shown

Filed	Form	Description
12/2/25	DEFA14A	DEFA14A	→
12/2/25	DEF 14A	DEF 14A	→
11/21/25	PRE 14A	PRE 14A	→
4/22/25	DEFA14A	DEFA14A	→
4/22/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
↓

Century Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(376 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/18/26	4	OWNERSHIP DOCUMENT	→
2/5/26	4	4	→
2/4/26	4	4	→
2/4/26	4	4	→
2/4/26	4	4	→
2/4/26	4	4	→
↓

Filed	Form	Description
2/17/26	EFFECT	EFFECT	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/16/26	SCHEDULE 13G	SCHEDULE 13G	→
1/16/26	SCHEDULE 13G	SCHEDULE 13G	→
1/16/26	SCHEDULE 13G	SCHEDULE 13G	→
1/15/26	SCHEDULE 13G	SCHEDULE 13G	→
↓